Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.225 USD | +0.41% | -6.49% | +16.67% |
07/05 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.67% | 87.3M | |
+23.37% | 47.02B | |
+50.07% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- ACRS Stock
- News Aclaris Therapeutics, Inc.
- Aclaris Therapeutics : HC Wainwright Adjusts Price Target on Aclaris Therapeutics to $50 From $40, Reiterates Buy Rating